Home
Ikarian Capital reported a 9% stake in Quince Therapeutics QNCX · 91,789 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 9%
- Last report
- First report
- Shares held
- 91,789 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- Ikarian Capital
- Event date
- 26/06/30
- Filed
- 26/08/14
First 5%+ report · 9% stake
Quince Therapeutics trades, last 26 weeks
What else happened in Quince Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Ikarian Capital's other 5% stake reports
- Ikarian Capital
5% stakeCNS Pharmaceuticals
5% stakeCNS Pharmaceuticals
CNSP
9.9% stake
147,290 sh
9.9% stake
Filed 08/14
- Ikarian Capital
5% stakeConnect Biopharma Holdings
5% stakeConnect Biopharma Holdings
CNTB
6.9% stake
4,338,534 sh
6.9% stake
Filed 08/14
- Ikarian Capital
5% stakeTenax Therapeutics
5% stakeTenax Therapeutics
TENX
2.9% stake
1,080,700 sh
2.9% stake
Filed 08/14
- Ikarian Capital
5% stakeInMed Pharmaceuticals
5% stakeInMed Pharmaceuticals
INM
4.2% stake
137,634 sh
4.2% stake
Filed 08/14
- Ikarian Capital
5% stakeKazia Therapeutics
5% stakeKazia Therapeutics
KZIA
4.9% stake
575,778 sh
4.9% stake
Filed 08/14
